Pancreatic Disease clinical trials

Explore recruiting pancreatic disease clinical trials.

Recruiting pancreatic disease studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pancreatic Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome. (STARS extend)

Spain, Denmark, Norway, Germany, France, Sweden +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomized, single-blind trial to evaluate the safety and efficacy of apraglutide in subjects with Grade II to IV (MAGIC) steroid refractory gastrointestinal (GI) acute graft versus host disease on best available therapy.

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Pancreatic Disease trials by city

Pancreatic Disease in Toronto Pancreatic Disease in Vancouver Pancreatic Disease in Montreal Pancreatic Disease in Calgary Pancreatic Disease in Edmonton Pancreatic Disease in Ottawa Pancreatic Disease in Winnipeg Pancreatic Disease in Quebec City Pancreatic Disease in Hamilton Pancreatic Disease in Kitchener Pancreatic Disease in London Pancreatic Disease in Halifax Pancreatic Disease in New York Pancreatic Disease in Los Angeles Pancreatic Disease in Chicago Pancreatic Disease in Houston

Pancreatic Disease clinical trials

Recruiting pancreatic disease studies right now

Intravital Microscopy in Human Solid Tumors

Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer

Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors

Trial Evaluating the Efficacy and the Safety of FOLFIRINOX3 Treatment in Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer in First Line of Chemotherapy

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies

Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors

Metronomic Capecitabine, Oxaliplatin and UGT1A1 Genotype-directed Irinotecan in Metastatic Pancreatic Cancer Patients

Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy

A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

Also recruiting in Europe

An Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome. (STARS extend)

A randomized, single-blind trial to evaluate the safety and efficacy of apraglutide in subjects with Grade II to IV (MAGIC) steroid refractory gastrointestinal (GI) acute graft versus host disease on best available therapy.

Pancreatic Disease trials by city

Other conditions